Zimmer Biomet’s Q3 sales dip slightly: 4 notes

Zimmer Biomet saw a less than 1 percent decrease in third quarter sales and growth in its hip and knee revenue, according to results posted Nov. 2.

Advertisement

Four things to know.

1. Net sales were $1.7 billion, a 0.9 percent decrease from the same time last year. U.S. sales were $973 million, and international sales were $696.8 million.

2. Knee sales of $657 million represent a 1.4 percent increase year-over-year. Hip sales grew 3.1 percent year-over-year at $468 million.

3. The sports medicine, extremities, trauma, craniomaxillofacial and thoracic business segment saw a 6.4 percent decrease in year-over-year sales with $409.4 million.

4. Net earnings were $194 million.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Orthopedic

Advertisement

Comments are closed.